Q&A with Dr. Jared Simpson
As scientists across Canada race to track the spread and evolution of COVID-19 through virus sequencing, software developed by Dr. Jared Simpson’s research team is enabling quality control of the samples being tested.
Q&A with Dr. Upton Allen
Q&A with Dr. Catalina Lopez‑Correa and Dr. Gary Van Domselaar
A new variant of the SARS-CoV-2 virus that spreads faster and more easily, is gaining a foothold in Canada—leaving researchers and public health officials asking if it will rapidly overtake the currently circulating strain.
When COVID-19 hit, Canada’s genomics research community stepped up immediately with strong responses for short-term containment and long-term management of the virus. But the pandemic is not the only area where smart investments in bio-innovation are making a difference.
The data generated by the virus sequencing initiative (VirusSeq) of the Canadian COVID-19 Genomics Network (CanCOGeN) will help track the transmission of SARS-CoV-2 (the virus that causes COVID-19), identify and monitor mutations that may influence disease severity or infectivity, and inform medical countermeasures.
The SARS-CoV-2 virus responsible for COVID-19 entered Quebec during the 2020 spring break period and may have been carried into the province by as few as 247 people, according to initial results from a study released on Sept. 21 by the Institut National de Santé Publique du Québec (INSPQ) and the McGill Genome Centre.